Sharechat Logo

RUA - Australian Licences received

Monday 26th June 2023

Text too small?

Rua Bioscience has received the required Licences to begin wholesale and trade activities of Rua branded medicinal cannabis products in Australia. In conjunction with its distributor in Australia, Rua plans to launch a range of products in Australia in Q3 2023.

 

Paul Naske, CEO of Rua Bioscience said, “We are excited about the prospect of launching in the Australian market. Our preferential supply agreement with Cann Group in Australia means we are very well placed to be able to grow our revenue in Australia.”

 

Medicinal cannabis in Australia was legalised in 2016 with a regulatory regime that has allowed for significant market growth. The market in calendar year 2022 was estimated to be A$240 million and it is still showing signs of very strong growth.1 Between H1 2022 and H2 2022 the number of units of medicinal cannabis products prescribed increased by 41%. This same data suggests a very conservative estimate of volume for the dried flower market last year was 13,000kg which does not include volume grown for other formulated products.

 

This launch of product into the Australian market follows closely on from our first exports into the German market. It’s an exciting period in Rua’s journey. Rua’s strategy of working with a network of supply partners and establishing pipelines of product in export markets is capital light. This allows the business to scale considerably, in-turn returning value to the shareholders and community of Tairawhiti.

 

For more information about Rua Bioscience please visit www.ruabioscience.com.

 

ENDS



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

GEN - Completion of Purchase of Premium Funding Business
Fletcher Building Announces Executive Appointment
WCO - Director independence determination
AIA - welcomes Ngahuia Leighton as 'Future Director'
Mercury announces Executive team changes
Fonterra launches Retail Bond Offer
October 29th Morning Report
BIF adds Zincovery to its investment portfolio
General Capital Resignation of Director
General Capital subsidiary General Finance update